screening tool to identify individuals with obstructive sleep apnoea (OSA) in a general population cohort. However, it has not been well studied in other clinical populations. We aimed to validate the NoSAS score in a clinic-based population and compare its performance to the Epworth Sleepiness Scale (ESS).
Methods:
We conducted a retrospective chart review of 500 patients who were referred to the sleep clinic. The NoSAS score was calculated based on available demographic and anthropometric data in addition to presence of self-reported snoring. All subjects underwent a full polysomnography. A NoSAS score of ≥8 points and an ESS of ≥10 points were classified as high risk for OSA. We defined severe OSA as an apnoeahypopnea index of ≥30 events/h.
Results:
The prevalence of severe OSA was 52.6%. The number of patients who were classified as high risk by the NoSAS score and ESS were 240 (48.0%) and 279 (55.8%), respectively. Overall the NoSAS score performed better than the ESS. The sensitivity, specificity, and negative and positive predictive value of the NoSAS score to predict severe OSA was 64.3, 70.0, 63.8 and 70.4%, respectively. The sensitivity, specificity, and negative and positive predictive value of the ESS to predict severe OSA was 58.6. 47.3%, 50.7% and 55.2%, respectively. The area under the curve values of NoSAS score (0.724) was higher than ESS (0.544). However, both scores did not perform well as screening tools for severe OSA in view of their low sensitivities and negative predictive values.
Conclusion:
Although the NoSAS score was superior to the ESS, both tools performed poorly in predicting severe obstructive sleep apnoea in a clinic-based population. Given the high prevalence of severe OSA in such patients, respiratory polygraphy or a full polysomnography may be needed to rule out sleep apnoea. Background and Aims: Secondary erythrocytosis from OSA is a result of intermittent hypoxia that occur during sleep. This is often undiagnosed until patient already presents with symptoms. We are going to present a case wherein an apparently healthy man presented with bothersome symptoms from an underlying disease.
Methods: Case Report
Results: A 50 year old male consulted at the outpatient department with chief complaint of cyanosis during sleep, flushed face and headaches. He claims to be asthmatic as a child with no recurrent attacks and was apparently well until a few months ago when he started having headaches, his wife notices that he turns blue when sleeping. A few weeks prior to consult he noticed shortness of breath then flushing of the face and bulging red eyes. He sought consult wherein lungs were clear but oxygen saturation is 78% at room air. His ABG revealed hypoxemia at room air (pO2 at 55), a stable left lung base fibrosis in chest X-ray,
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